Actively Recruiting
Surgical Treatment of Recurrent Shoulder Dislocations
Led by Nova Scotia Health Authority · Updated on 2026-05-04
200
Participants Needed
2
Research Sites
296 weeks
Total Duration
On this page
Sponsors
N
Nova Scotia Health Authority
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a pilot multi-centre, double blinded randomized controlled trial. The primary outcome of this pilot trial will be feasibility. Prior to conducting a large definitive trial, the investigators will conduct this pilot trial comparing arthroscopic Bankart repair with arthroscopic anatomic glenoid reconstruction (AAGR), evaluating recurrent dislocation rates and functional outcomes over a 24-month period. The feasibility objectives are: (1) to evaluate the investigators ability to recruit patients across multiple sites and (2) to assess study protocol adherence and ability to follow patients to 24 months. Clinical objectives for the pilot trial are exploratory only. The investigators wish to gather means and standard deviations for clinical outcomes to power their future definitive trial. The objectives of the definitive trial will include a comparison of patient-reported outcomes at the two-year post-operative time point, differences in recurrence rates, complication rates, functional shoulder assessments, and return to work/sport.
CONDITIONS
Official Title
Surgical Treatment of Recurrent Shoulder Dislocations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recurrent anterior glenohumeral dislocation (two or more incidents)
- Presence of glenoid and/or humerus bone loss on imaging (x Ray, CT or MRI)
You will not qualify if you...
- Uncontrolled diabetes (Hgb A1C >7%)
- Prior surgery of affected shoulder
- Pregnancy
- Multidirectional instability
- Posterior instability
- Paralysis of the shoulder
- Cancer
- Severe systemic illness
- Presence of massive rotator cuff tear
- Patients that present with < 10% or > 25% bone loss under preoperative imaging.
- Generalized laxity (>5/9 Beighton Score)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
2
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada, B3H 2E1
Actively Recruiting
Research Team
M
Matt Miller, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here